ARPO Aerpio Pharmaceuticals Inc

DGAP-News: MC Services AG hosts press lounge of German Equity Forum 2018

DGAP-News: MC Services AG / Key word(s): Conference
MC Services AG hosts press lounge of German Equity Forum 2018

13.11.2018 / 09:30
The issuer is solely responsible for the content of this announcement.


Press Release

MC Services AG hosts press lounge of German Equity Forum 2018

Munich and Dusseldorf, November 13, 2018: MC Services AG, the international Public Relations and Investor Relations firm is, once again, sponsoring the "Deutsches Eigenkapitalforum" (German Equity Forum) and will host the event's press lounge. The Forum will be held in Frankfurt am Main, November 26-28, 2018.

Deutsches Eigenkapitalforum, which is organized by the Deutsche Boerse, is Europe's largest independent capital markets meeting, which this year is reporting record figures with more than 250 registered companies and an expected 3,500 1 to 1 meetings. As a matching platform, the forum connects capital-seeking German and international companies from all industry sectors with institutional investors and analysts.

To establish new contacts and to deepen existing liaisons between the press, companies and financial community, MC Services AG invites financial and economic journalists to the press lounge and organizes a smooth flow of the schedule for all participants.

"For the sixth year now, we are proud to have the confidence of the Deutsche Boerse, as a partner to the Eigenkapitalforum," said Raimund Gabriel, Founder and Managing Partner of MC Services AG. "As the host of the Eigenkapitalforum press lounge, it is important for MC Services to offer thorough organization and a pleasant environment for discussions between reporters and companies. The steady increase in the number of press lounge visitors and interviews confirms the real benefits of the MC Services press lounge."

For more than 20 years, the Deutsches Eigenkapitalforum has hosted company representatives of all industries and facilitated meetings with the financial community. The Forum will take place at the Sheraton Frankfurt Airport Hotel and Conference Center in Frankfurt am Main on November 26-28, 2018. The three-day program offers panels on the latest capital markets topics, 1 to 1 meetings and company presentations. On Tuesday and Wednesday, captivating young private companies from a whole range of sectors will deliver presentations to investors and reporters. As in previous years, the presentations of the companies being listed in the Venture Network of the Deutsche Boerse will be accessible to all participants of the conference.

Further information on the program and venue can be found on the event website () or on the MC Services .

About MC Services AG
MC Services AG is an international public relations and investor relations firm. A strong team of finance, media and communication experts as well as natural scientists with extensive industry experience positions MC Services as one of the leading agencies in Europe. MC Services' long-standing clients include international public and private companies as well as venture capitalists and investment firms. Established for many years as a link between companies and financial markets, MC Services provides comprehensive services in investor relations, public relations and financial transactions. MC Services is based in Munich, Düsseldorf, London and Boston.

Contact
Raimund Gabriel
MC Services AG

Phone: 0
Fax: 88
Email:



13.11.2018 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at


744837  13.11.2018 

fncls.ssp?fn=show_t_gif&application_id=744837&application_name=news&site_id=research_pool
EN
13/11/2018

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Aerpio Pharmaceuticals Inc

 PRESS RELEASE

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes

Aadi Bioscience to Join Russell 2000® and Russell 3000® Indexes LOS ANGELES, June 23, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced it will join both the U.S. small cap Russell 2000® Index and broad-market Russell 3000® Index at the conclusion of the 2022 Russell indexes annual reconstitution, effective immediately after the U.S. market opens on June 24, 2022 according to a preliminary list of add...

 PRESS RELEASE

Aadi Bioscience to Present at the Jefferies Global Healthcare Conferen...

Aadi Bioscience to Present at the Jefferies Global Healthcare Conference LOS ANGELES, June 01, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced members of the Aadi senior management team will participate in the Jefferies Global Healthcare Conference, to be held in New York, NY June 8-10, 2022. Founder, Chief Executive Officer and President, Neil Desai, Ph.D. is scheduled to present live during a fire...

 PRESS RELEASE

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor R...

Aadi Bioscience Appoints Marcy Graham Senior Vice President Investor Relations and Corporate Communications LOS ANGELES, May 31, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced the appointment of Marcy Graham to the new position of Senior Vice President, Investor Relations (IR) and Corporate Communications. “We are delighted to welcome Marcy to the team, as she brings extensive experience to ...

 PRESS RELEASE

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in ...

Aadi Bioscience Announces Exploratory Biomarker Data from Patients in Its AMPECT Trial and Expanded Access Program to be Presented at 2022 ASCO Annual Meeting Target tumor reductions observed in advanced malignant PEComa patients harboring TSC1 or TSC2 inactivating alterations regardless of prior mTOR inhibitor exposure LOS ANGELES, May 26, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (NASDAQ: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes, today announced presentat...

 PRESS RELEASE

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Co...

Aadi Bioscience to Present at the H.C. Wainwright Global Investment Conference LOS ANGELES, May 18, 2022 (GLOBE NEWSWIRE) -- Aadi Bioscience, Inc. (Nasdaq: AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for genetically-defined cancers with alterations in mTOR pathway genes, today announced that Founder, Chief Executive Officer and President, Neil Desai, Ph.D., and senior members of Aadi’s executive team will participate virtually in the H.C. Wainwright Global Investment Conference, to be held in person and virtually May 23-26, 2022 in Mia...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch